BALAJI AMINES LTD.-$
P&L
Quarterly Consolidated
vs Q1 FY26
Balaji Amines Q2FY26 Revenue at ₹ 341 Crore, EBITDA at ₹ 67 Crore, Net Profit at ₹ 37 Crore
11 Nov 2025 · 11 Nov 2025, 04:16 pm
Summary
Balaji Amines Limited, a leading manufacturer of Aliphatic Amines & Speciality Chemicals in India, announced its unaudited financial results for the quarter ended September 30, 2025. The company reported a consolidated Q2FY26 revenue of ₹ 341 crore, EBITDA of ₹ 67 crore, and net profit of ₹ 37 crore. The company maintains stable operational performance with similar sales volumes as last year, supported by stable commodity prices and consistent demand across key segments.
Key Highlights
- 1
Q2FY26 Revenue stood at ₹ 341 Crore
- 2
EBITDA stood at ₹ 67 Crore
- 3
Net Profit stood at ₹ 37 Crore
- 4
Sales Volume (in MT) for Q2 FY26 stood at 26,165 MT
- 5
New Projects Commissioned: DME Plant at Unit-IV and N-Methyl Morpholine (NMM) - 5000 TPA
- 6
New Proposed Products/Projects: Expansion of Rs. 750 crs in Subsidiary Balaji Speciality Chemicals Limited
Management Comments
Mr. D. Ram Reddy
Managing Director
During the quarter and period ended 30th September 2025, overall operations remained muted compared to the previous quarters, largely due to lower offtake in the pharma and agrichem sectors amid prevailing geopolitical uncertainties. With several projects progressing as planned, the company anticipates a gradual improvement in operational momentum in the coming quarters as new capacities become operational.
Informational and educational content only. Not investment advice.